Nigel Kirby
About
Nigel Kirby is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Clinical Biochemistry.
According to data from OpenAlex, Nigel Kirby has authored 21 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Epidemiology and 6 papers in Clinical Biochemistry. Recurrent topics in Nigel Kirby's work include Bacterial Identification and Susceptibility Testing (6 papers), Urinary Tract Infections Management (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Nigel Kirby is often cited by papers focused on Bacterial Identification and Susceptibility Testing (6 papers), Urinary Tract Infections Management (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Nigel Kirby collaborates with scholars based in United Kingdom, Netherlands and Spain. Nigel Kirby's co-authors include Kerenza Hood, Emma Thomas‐Jones, David Gillespie, Nick Francis, Christopher Butler, Janine Bates, Carl Llor, Micaela Gal, Mandy Wootton and Jeremy Howick and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.
In The Last Decade
Nigel Kirby
20 papers receiving 399 citations
Peers
Nigel Kirby
Sophie E. Katz United States
Sarah Jamali Lebanon
Ellen Berni United Kingdom
Rebecca Dezube United States
Miriam Elman United States
Evert‐Jan Wils Netherlands
Pär‐Daniel Sundvall Sweden
Nicole Werner Germany
Eleni Agakidou Greece
Julius Chacha Mwita Botswana
Citations per year, relative to Nigel Kirby Nigel Kirby (= 1×)
peers
Sophie E. Katz
Countries citing papers authored by Nigel Kirby
Since
Specialization
Citations
This map shows the geographic impact of Nigel Kirby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Kirby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Kirby more than expected).
Fields of papers citing papers by Nigel Kirby
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nigel Kirby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Kirby. The network helps show where Nigel Kirby may publish in the future.
Co-authorship network of co-authors of Nigel Kirby
This figure shows the co-authorship network connecting the top 25 collaborators of Nigel Kirby. A scholar is included among the top collaborators of Nigel Kirby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel Kirby. Nigel Kirby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Gillespie, David, Nick Francis, Haroon Ahmed, et al.. (2022). Associations with Post-Consultation Health-Status in Primary Care Managed Acute Exacerbation of COPD. SHILAP Revista de lepidopterología.
2.
Gillespie, David, Christopher Butler, Janine Bates, et al.. (2021). Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial. British Journal of General Practice. 71(705). e266–e272.
3.
Banerjee, Jayanta, Edward Mullins, Julia Townson, et al.. (2021). Pregnancy and neonatal outcomes in COVID-19: study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention. BMJ Open. 11(1). e041247–e041247.
4.
Abbott, Rachel, B. J. Lloyd, Rebecca Cannings‐John, et al.. (2021). Observational study to estimate the proportion of surgical site infection following excision of ulcerated skin tumours (OASIS study). Clinical and Experimental Dermatology. 47(5). 882–888.
5.
Metryka, Aleksandra, Hazel Evans, Nigel Kirby, et al.. (2021). Study protocol for randomised clinical trial comparing the effectiveness of side-lying sleep positioning to back-lying at reducing oxygen desaturation resulting from obstructive sleep apnoea in infants with cleft palate (SLUMBRS2). BMJ Open. 11(4). e049290–e049290.
6.
Drew, Cheney, Elizabeth Randell, Lucy Brookes‐Howell, et al.. (2021). Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington’s disease. Brain Communications. 3(1). fcaa230–fcaa230.
7.
Lowe, John, David Gillespie, Lei Zhang, et al.. (2020). Study protocol: azithromycin therapy for chronic lung disease of prematurity (AZTEC) - a randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants. BMJ Open. 10(10). e041528–e041528.
8.
Kirby, Nigel, et al.. (2020). Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials. Trials. 21(1). 658–658.
9.
Brookes‐Howell, Lucy, Emma Thomas‐Jones, Janine Bates, et al.. (2019). Challenges in managing urinary tract infection and the potential of a point-of-care test guided care in primary care: an international qualitative study. BJGP Open. 3(2). bjgpopen18X101630–bjgpopen18X101630.
10.
Butler, Christopher, David Gillespie, Patrick White, et al.. (2019). C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. New England Journal of Medicine. 381(2). 111–120.
11.
Butler, Christopher, Nick Francis, Emma Thomas‐Jones, et al.. (2018). Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness. British Journal of General Practice. 68(669). e268–e278.
12.
Howick, Jeremy, Rebecca Webster, Nigel Kirby, & Kerenza Hood. (2018). Rapid overview of systematic reviews of nocebo effects reported by patients taking placebos in clinical trials. Trials. 19(1). 674–674.
13.
Butler, Christopher, David Gillespie, Patrick White, et al.. (2018). Late Breaking Abstract - Trial of c-reactive protein point of care testing (CRP-POCT) for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD) in primary care. OA284–OA284.
14.
Rasmussen, Klaus, Donna Cohén, Tony Y. Eng, et al.. (2018). The Analytical Hierarchy Process (AHP) to Score Plan Quality of Intact Prostate Treatment Plans. International Journal of Radiation Oncology*Biology*Physics. 102(3). e534–e534.
15.
Wootton, Mandy, Theo Verheij, Emma Thomas‐Jones, et al.. (2017). Clinicians’ interpretations of point of care urine culture versus laboratory culture results: analysis from the four-country POETIC trial of diagnosis of uncomplicated urinary tract infection in primary care. Family Practice. 34(4). 392–399.
16.
Butler, Christopher, Nick Francis, Emma Thomas‐Jones, et al.. (2017). Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study. British Journal of General Practice. 67(665). e830–e841.
17.
Randell, Elizabeth, Rachel McNamara, Eleri Owen-Jones, et al.. (2016). Additional file 1: of The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial. Figshare.
18.
Randell, Elizabeth, Rachel McNamara, D. M. Davies, et al.. (2016). The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial. Trials. 17(1). 398–398.
19.
Bates, Janine, Emma Thomas‐Jones, Nigel Kirby, et al.. (2013). Effects of an optimised POCT guided diagnostic and treatment strategy for symptoms of uncomplicated UTI on use of appropriate antibiotics and uptake into primary care practice. Trials. 14(S1).
20.
Kirby, Nigel. (1968). Pancreatic Extracts in Cystic Fibrosis. BMJ. 3(5613). 316.4–316.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Sophie E. Katz Breakdown of academic impact, for papers by Sarah Jamali Breakdown of academic impact, for papers by Ellen Berni Breakdown of academic impact, for papers by Rebecca Dezube Breakdown of academic impact, for papers by Miriam Elman Breakdown of academic impact, for papers by Evert‐Jan Wils Breakdown of academic impact, for papers by Pär‐Daniel Sundvall Breakdown of academic impact, for papers by Nicole Werner Breakdown of academic impact, for papers by Eleni Agakidou Breakdown of academic impact, for papers by Julius Chacha Mwita